Sublime

🧬 Biopharma 𝕏 Weekly Recap 📝 Interesting posts/ppl to check out! 👇 🚨 @yaireinhorn Biotech sector shrinks as public biotech companies drop 15% since 2022 📉 » https://t.co/G11bvicBe5 🔬 @GeneInvesting Side-by-side... See more

Obesity Comp - in a single graph (from 340 pgs long Obesity report by Stifel) https://t.co/tS4KgA0zZs

Labcorp quietly entered the longevity testing game. Their new Whole Health panel covers 1,000+ biomarkers—similar to what startups like Function & Superpower offer, but DTC. As labs make these moves, the value will shift to interpretation, care, and outcomes. https://t.co/4kEoQoxgst

We just published an overview on some of the key names and developments in the picks-and-shovels space for the biotech industry. And there's also a deep dive on a strongly positioned player, we came across this company via a scientist at a major pharma company who mentioned how he is relying on this company. It’s a name we had never even heard of... See more

This is one of the best biotech 'request for startups' I've seen. Virtually all of these are also on my personal list of companies I'd like to help / support / invest in. https://t.co/jIV21kl4fn

List of approved Gene Therapies **best selling is ZOLGENSMA w/ 2021 ~$1.4B Revs https://t.co/fsNh706DHv

Biopharma Industry Growth by Drug Modality (2017-2026) https://t.co/pYLtgeAWZs

Curious about salaries in biotech? r/biotech's annual survey data for 2024 is out. With 700+ entries showing a range from $400k - $30k in annual base. Leadership roles earn significantly more and the inflection point is at director level and up. Link below👇 https://t.co/dQs0Np4OlK

3 out of 4 drug approvals come from biotech companies! And half of the projected value of Top 20 pharma drug pipelines also come from "external" innovation, meaning smaller biotech.